Comments
Loading...
Actuate Therapeutics (ACTU) Forecast
NewsEarningsActuate Therapeutics (ACTU) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestActuate Therapeutics (NASDAQ:ACTU) Stock Quotes, Forecast and News Summary
Actuate Therapeutics Stock (NASDAQ: ACTU) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Actuate Therapeutics (ACTU) stock?
You can purchase shares of Actuate Therapeutics (NASDAQ:ACTU) through any online brokerage.
Who are Actuate Therapeutics (ACTU) competitors?
Other companies in Actuate Therapeutics’s space includes: Molecular Partners (NASDAQ:MOLN), Macrogenics (NASDAQ:MGNX), Innate Pharma (NASDAQ:IPHA), Zentalis Pharma (NASDAQ:ZNTL) and Adaptimmune Therapeutics (NASDAQ:ADAP).
What is the forecast, or price target, for Actuate Therapeutics (ACTU) stock?
There is no analysis for Actuate Therapeutics to provide a consensus price target.
What is the current price for Actuate Therapeutics (ACTU)?
The stock price for Actuate Therapeutics (NASDAQ: ACTU) is $7.975 last updated February 12, 2025 at 10:43 AM EST.
Does Actuate Therapeutics (ACTU) pay a dividend?
There are no upcoming dividends for Actuate Therapeutics.
When is Actuate Therapeutics (NASDAQ:ACTU) reporting earnings?
Actuate Therapeutics’s Q4 earnings are confirmed for Tuesday, February 25, 2025.
Is Actuate Therapeutics (ACTU) going to split?
There is no upcoming split for Actuate Therapeutics.
What sector and industry does Actuate Therapeutics (ACTU) operate in?
Actuate Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.